CytoDyn Inc
General ticker "CYDY" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $137.8M
CytoDyn Inc does not follow the US Stock Market performance with the rate: -28.5%.
Estimated limits based on current volatility of 5.5%: low 0.11$, high 0.13$
Factors to consider:
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-05-31 to 2026-05-31
- 2024-05-31 to 2025-05-31 estimated range: [0.12$, 0.33$]
- 2025-05-31 to 2026-05-31 estimated range: [0.10$, 0.29$]
Short-term CYDY quotes
Long-term CYDY plot with estimates
Financial data
| YTD | 2024-05-31 |
|---|---|
| Operating Revenue | $0.00MM |
| Operating Expenses | $18.06MM |
| Operating Income | $-18.06MM |
| Non-Operating Income | $-31.78MM |
| Interest Expense | $8.67MM |
| R&D Expense | $7.24MM |
| Income(Loss) | $-49.84MM |
| Profit(Loss) | $-49.84MM |
| Stockholders Equity | $-116.76MM |
| Assets | $11.14MM |
| Operating Cash Flow | $-10.98MM |
| Financing Cash Flow | $11.75MM |
| Earnings Per Share* | $-0.05 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.